Drug Immunology

Briumvi

Payments companies reported to CMS as associated with Briumvi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$13Massociated payments (2023-2025)
5,921clinicians with associated payments
2companies reporting

By year

2023 $2.6M
2024 $4.7M
2025 $6.2M

Payments reported as associated with Briumvi, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $10.0M
Hematology (Internal Medicine) $1.4M
Family $524K
Physician Assistant $216K
Clinical Neurophysiology $192K
Adult Health (Nurse Practitioner) $155K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Briumvi

These are the largest totals companies reported as associated with Briumvi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Sagar Lonial Atlanta, GA Hematology (Internal Medicine) $1,378,544.16
Mary Ann Picone Teaneck, NJ Neurology (Psychiatry & Neurology) $315,243.33
Kenneth Mankowski Columbus, OH Neurology (Psychiatry & Neurology) $199,946.21
Barry Singer Saint Louis, MO Neurology (Psychiatry & Neurology) $194,019.36
Aram Zabeti Cincinnati, OH Neurology (Psychiatry & Neurology) $189,763.20
Daniel Bandari Newport Beach, CA Neurology (Psychiatry & Neurology) $185,098.40
Matthew Carraro Charlotte, NC Neurology (Psychiatry & Neurology) $173,387.69
Pavle Repovic Seattle, WA Neurology (Psychiatry & Neurology) $169,007.64
Mirla Avila Lubbock, TX Neurology (Psychiatry & Neurology) $164,970.32
Stephen Krieger New York, NY Neurology (Psychiatry & Neurology) $164,835.41

Prescribed Briumvi?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.